Skip to main content

Table 3 Cost-Utility Analysis

From: Cost-utility analysis and net monetary benefit of Platelet Rich Plasma (PRP), intra-articular injections in compared to Plasma Rich in Growth Factors (PRGF), Hyaluronic Acid (HA) and ozone in knee osteoarthritis in Iran

Strategy

Cost ($)

Incremental Cost ($)

Effect

Incremental Eff

ICER

NMB ($)

Oz

103.20

0

0.64

0.00

0

6316.77

PRP

318.58

215.38

0.67

0.03

7583.16

6385.40

PRGF

328.10

9.52

0.67

0.00

-

6375.88

HA

581.67

263.09

0.65

-0.02

-10,871.70

5880.31

Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us